Meropenem-Vaborbactam

meropenem-vaborbactam · Melinta Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Meropenem-Vaborbactam, covering 2017-10-26 to 2019-01-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia [Phase 3]

See pricing